glp 1 en farmacias Arkopharma lanza un concentrado vegetal saciante que actúa sobre la vía del Los GLP-1 desatan una ola

As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so too does our knowledge of just what all these medications can do

An observational study in Neurology found that GLP1 diabetes drugs were associated with a lower risk of developing epilepsy compared with DPP4 inhibitors

GLP-1s are proving their value well beyond the scale, with benefits ranging from improved glycemic control and reduced cardiovascular risk to better mobility and quality of life

Carmot gets $150 million to finance its obesity pipeline

Taking semaglutide and Synthroid together requires careful coordination

What companies are topping biotech IPOs in 2026?ParabilisMedicines with a focus on alpha-helical peptides andKaileraTherapeutics specializing in GLP-1s and related drugs for obesity are leading the way